Published in AIDS Weekly, May 10th, 1999
The study, published in the Journal of Virology (May 1999;73(5):4145-4155), was conducted in collaboration with the Aaron Diamond AIDS Research Center (ADARC) in New York.
PRO 140 targets CCR5, a protein expressed on the surface of certain immune system cells that provide targets for HIV infection. In 1996, researchers at Progenics and ADARC identified the human protein CCR5 to be a co-receptor required for HIV isolates to fuse with and infect target cells. Individuals who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.